Author(s): Shoaib Ahmad

Email(s): shoaibahmad1999@gmail.com

DOI: 10.5958/0975-4377.2016.00041.0   

Address: Dr. Shoaib Ahmad
University School of Pharmaceutical Sciences, Rayat-Bahra University, Mohali 140104 India
*Corresponding Author

Published In:   Volume - 8,      Issue - 4,     Year - 2016


ABSTRACT:
Ambroxol hydrochloride (trans-4-[(2-amino-3,5-dibrom-benzyl)amino]cyclohexano hydrochloride; CAS 18683-91-5) is a mucolytic agent. It is an ingredient of several cough and cold formulations – particularly syrups and tablets. The pharmacological properties (i.e. anesthetic, analgesic and anti-inflammatory) have aroused the interest of the scientific community in this molecule. As a result, many studies have focused on the formulation of the lozenges of ambroxol hydrochloride. The commercial marketing of these lozenges started in the year 2002. The reported strengths of these lozenges are 15, 20, and 30 mg. The studies have indicated that bioavailability of the drug from lozenges is better than the tablets. It is so apparently because dissolution of the lozenges in the mouth itself adds to the systemic circulation. Hence, the lozenges can be better candidate for treating respiratory tract problems and associated symptoms. The lozenges are usually well tolerated. The present communication is an attempt to present an overview of the recent developments concerning ambroxol hydrochloride lozenges.


Cite this article:
Shoaib Ahmad. Ambroxol Lozenges: Introduction and Recent Advances. Res. J. Pharm. Dosage Form. & Tech. 2016; 8(4): 296-297. doi: 10.5958/0975-4377.2016.00041.0


Recomonded Articles:

Author(s): V. S. Parmar, S.C. Shivhare

DOI:         Access: Open Access Read More

Author(s): Domendra Sahu, Shekhar Verma , Ravindra D. Dubey

DOI:         Access: Open Access Read More

Author(s): Dipti G. Phadtare, Amol R. Pawar, R.B. Saudagar, Govind K.Patil

DOI: 10.5958/0975-4377.2017.00002.7         Access: Open Access Read More

Author(s): Vinod K.R., Sandhya S

DOI:         Access: Open Access Read More

Author(s): Yamunappa, Ravi Kumar, Pooja Shetty, Prathibha Suvarna, Narayana Swamy VB

DOI: 10.5958/0975-4377.2016.00012.4         Access: Open Access Read More

Author(s): A Maru, U Pattamatta , VB Patravale

DOI:         Access: Open Access Read More

Author(s): Gopal Rao M., M. A. Amutha Gnana Arasi, S. Jayaprakash, M. Arun Kumar, P. Kavitha

DOI:         Access: Open Access Read More

Author(s): Hapse S.A., Bhagat B.V., Wagh V.S. , Kadaskar P.T.

DOI:         Access: Open Access Read More

Author(s): Swapnil T. Deshpande, P. S. Vishwe, Rohit D. Shah, Swati S. Korabu, Bhakti R. Chorghe, DG Baheti

DOI:         Access: Open Access Read More

Author(s): Debarupa Dutta, Prithviraj Chakraborty

DOI:         Access: Open Access Read More

Author(s): Simila Madathil, RaviKumar, Anju Govind, Mercy Mathew, Narayana Swamy VB

DOI: 10.5958/0975-4377.2016.00013.6         Access: Open Access Read More

Author(s): Dharmendra Kumar Kushwah, Prakash Yashwant Kohle, Bimal Kumar Srivastava, Manoj Parmar ,Dhaval Mehta

DOI:         Access: Open Access Read More

Author(s): Patil Namrata D., Gondkar S.B., Saudagar R.B.

DOI: 10.5958/0975-4377.2016.00033.1         Access: Open Access Read More

Author(s): Chirag A. Patel, Priyal R. Patel, Dhrubo Jyoti Sen,Jayvadan K. Patel

DOI:         Access: Open Access Read More

Author(s): Dilip M. Kumbhar, Kailas K. Mali, Remeth J. Dias, Vijay D. Havaldar, Vishwajeet S. Ghorpade, Nitin H. Salunkhe.

DOI: 10.5958/0975-4377.2016.00036.7         Access: Open Access Read More

Author(s): Hardik B. Rana, Kajol Patel, Mansi Dholakia, Vaishali T. Thakkar, Mukesh C. Gohel, Tejal R. Gandhi

DOI: 10.5958/0975-4377.2017.00006.4         Access: Open Access Read More

Research Journal of Pharmaceutical Dosage Forms and Technology (RJPDFT) is an international, peer-reviewed journal, devoted to pharmaceutical sciences. ...... Read more >>>

RNI: Not Available                     
DOI: 10.5958/0975-4377 


Recent Articles




Tags